Jose S. Dinis

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinoma.

Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinoma.

Journal: ESMO open

Published: September 05, 2025

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Journal: JAMA

Published: March 13, 2025

INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 10, 2025

Treatment of Locally Advanced and Metastatic Salivary Gland Cancer: A 10-year Experience of an Oncology Center in Portugal.

Treatment of Locally Advanced and Metastatic Salivary Gland Cancer: A 10-year Experience of an Oncology Center in Portugal.

Journal: Acta medica portuguesa

Published: December 31, 2024

Efficacy and safety of induction chemotherapy in oral cavity cancer: An eight-year experience at a Portuguese reference center.

Efficacy and safety of induction chemotherapy in oral cavity cancer: An eight-year experience at a Portuguese reference center.

Journal: Tumori

Published: June 03, 2024

A New Era in Salivary Gland Carcinoma Treatment: A Case Report.

A New Era in Salivary Gland Carcinoma Treatment: A Case Report.

Journal: Cureus

Published: August 03, 2023

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence.

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence.

Journal: Oral oncology

Published: April 25, 2023

A 10-year review of primary major salivary gland cancers.

A 10-year review of primary major salivary gland cancers.

Journal: Ecancermedicalscience

Published: December 19, 2019

Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.

Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.

Journal: Journal of the National Cancer Institute

Published: August 28, 2019

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Journal: JAMA oncology

Published: June 14, 2019

Management of Locally Advanced Esthesioneuroblastoma in a Pregnant Woman.

Management of Locally Advanced Esthesioneuroblastoma in a Pregnant Woman.

Journal: Case reports in oncological medicine

Published: February 05, 2019

A new numerical approach to mechanically analyse biological structures.

A new numerical approach to mechanically analyse biological structures.

Journal: Computer methods in biomechanics and biomedical engineering

Published: December 25, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026